Connect with us

Business

The Starpharma (ASX:SPL) share price is 35% below its 52-week high

Published

on

Shares in mid-cap ASX biopharmaceuticals company Starpharma Holdings Limited (ASX: SPL) have endured a volatile start to 2021. After surging to an all-time high of $2.52 by mid-February, the company’s shares have now plunged more than 35% to just $1.62 as at the time of writing.

While…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Why green hydrogen is in the news again and 3 ASX shares in the sector
What’s happening with the CBA (ASX:CBA) share price?